Cerezyme® (imiglucerase)
| Full Name | Cerezyme® (imiglucerase) |
| Drug | Cerezyme |
| Manufacturer | Sanofi Genzyme |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia, thrombocytopenia, bone disease, hepatomegaly or splenomegaly |
| Disease | Gaucher Type I Disease |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | cerezyme.com/hcp |
| Patient Resources | National Niemann Pick Disease Foundation |